Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wagner S Brum

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Molecular Psychiatry|September 4, 2025
Association between FDG- and TSPO-PET signals across human and animal studies investigating neurodegenerative conditions: a systematic reviewLuiza S Machado, Pedro Vidor, Lavínia Perquim, et al.
JAMA Neurology|January 22, 2024
Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease PathologyNicholas J Ashton, Wagner S Brum, Guglielmo Di Molfetta, et al.
Acta Neuropathologica|September 30, 2025
Reversible tau hyperphosphorylation in hibernation: a blood biomarker and brain tissue studyWagner S Brum, Laia Montoliu-Gaya, Gunnar Brinkmalm, et al.
Molecular Psychiatry|September 8, 2025
Diagnostic performance of Alzheimer's disease blood and CSF biomarkers in a Brazilian cohort with low educational attainmentWyllians Vendramini Borelli, Pamela C L Ferreira, Wagner S Brum, et al.
Neurology|August 21, 2024
Influence of Different Diagnostic Criteria on Alzheimer Disease Clinical ResearchAndrei Bieger, Wagner S Brum, Wyllians V Borelli, et al.
Medrxiv : the Preprint Server for Health Sciences|July 28, 2023
Diagnostic accuracy of the plasma ALZpath pTau217 immunoassay to identify Alzheimer's disease pathologyNicholas J Ashton, Wagner S Brum, Guglielmo Di Molfetta, et al.
Molecular Psychiatry|December 8, 2022
Genetic risk for attention-deficit/hyperactivity disorder predicts cognitive decline and development of Alzheimer's disease pathophysiology in cognitively unimpaired older adultsDouglas T Leffa, João Pedro Ferrari-Souza, Bruna Bellaver, et al.
Ebiomedicine|April 1, 2023
Plasma and cerebrospinal fluid glial fibrillary acidic protein levels in adults with Down syndrome: a longitudinal cohort studyLaia Montoliu-Gaya, Daniel Alcolea, Nicholas J Ashton, et al.
Neurobiology of Aging|February 9, 2024
Vascular risk burden is a key player in the early progression of Alzheimer's diseaseJoão Pedro Ferrari-Souza, Wagner S Brum, Lucas A Hauschild, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 3, 2023
Plasma p-tau231 and p-tau217 inform on tau tangles aggregation in cognitively impaired individualsPamela C L Ferreira, Joseph Therriault, Cécile Tissot, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Molecular Psychiatry|September 4, 2025
Association between FDG- and TSPO-PET signals across human and animal studies investigating neurodegenerative conditions: a systematic reviewLuiza S Machado, Pedro Vidor, Lavínia Perquim, et al.
JAMA Neurology|January 22, 2024
Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease PathologyNicholas J Ashton, Wagner S Brum, Guglielmo Di Molfetta, et al.
Acta Neuropathologica|September 30, 2025
Reversible tau hyperphosphorylation in hibernation: a blood biomarker and brain tissue studyWagner S Brum, Laia Montoliu-Gaya, Gunnar Brinkmalm, et al.
Molecular Psychiatry|September 8, 2025
Diagnostic performance of Alzheimer's disease blood and CSF biomarkers in a Brazilian cohort with low educational attainmentWyllians Vendramini Borelli, Pamela C L Ferreira, Wagner S Brum, et al.
Neurology|August 21, 2024
Influence of Different Diagnostic Criteria on Alzheimer Disease Clinical ResearchAndrei Bieger, Wagner S Brum, Wyllians V Borelli, et al.
Medrxiv : the Preprint Server for Health Sciences|July 28, 2023
Diagnostic accuracy of the plasma ALZpath pTau217 immunoassay to identify Alzheimer's disease pathologyNicholas J Ashton, Wagner S Brum, Guglielmo Di Molfetta, et al.
Molecular Psychiatry|December 8, 2022
Genetic risk for attention-deficit/hyperactivity disorder predicts cognitive decline and development of Alzheimer's disease pathophysiology in cognitively unimpaired older adultsDouglas T Leffa, João Pedro Ferrari-Souza, Bruna Bellaver, et al.
Ebiomedicine|April 1, 2023
Plasma and cerebrospinal fluid glial fibrillary acidic protein levels in adults with Down syndrome: a longitudinal cohort studyLaia Montoliu-Gaya, Daniel Alcolea, Nicholas J Ashton, et al.
Neurobiology of Aging|February 9, 2024
Vascular risk burden is a key player in the early progression of Alzheimer's diseaseJoão Pedro Ferrari-Souza, Wagner S Brum, Lucas A Hauschild, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 3, 2023
Plasma p-tau231 and p-tau217 inform on tau tangles aggregation in cognitively impaired individualsPamela C L Ferreira, Joseph Therriault, Cécile Tissot, et al.
Pageof 6